LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.81 | 84.90 | 1642 | 1769 | 0.9280 | 0.9662 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 26.51 | 84.90 | 43 | 1923 | 0.0224 | -0.1403 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 26.51 | 84.90 | 1552 | 1923 | 0.8070 | 0.9070 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 26.51 | 84.90 | 40 | 1923 | 0.0208 | -0.1540 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 26.51 | 84.90 | 1783 | 1923 | 0.9271 | 0.9667 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 28.21 | 84.90 | 46 | 2091 | 0.0220 | -0.1242 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 28.21 | 84.90 | 1636 | 2091 | 0.7822 | 0.8965 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 28.21 | 84.90 | 53 | 2091 | 0.0253 | -0.0969 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 28.21 | 84.90 | 1871 | 2091 | 0.8946 | 0.9524 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 29.92 | 84.90 | 57 | 2237 | 0.0255 | -0.0809 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 29.92 | 84.90 | 1739 | 2237 | 0.7771 | 0.8960 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 29.92 | 84.90 | 72 | 2237 | 0.0322 | -0.0343 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 29.92 | 84.90 | 2022 | 2237 | 0.9036 | 0.9575 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 31.62 | 84.90 | 37 | 2449 | 0.0151 | -0.1574 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 31.62 | 84.90 | 1852 | 2449 | 0.7560 | 0.8879 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 31.62 | 84.90 | 83 | 2449 | 0.0339 | -0.0046 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 31.62 | 84.90 | 2182 | 2449 | 0.8907 | 0.9529 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 33.32 | 84.90 | 73 | 2722 | 0.0268 | -0.0297 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 33.32 | 84.90 | 1994 | 2722 | 0.7324 | 0.8793 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 33.32 | 84.90 | 85 | 2722 | 0.0312 | 0.0002 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 33.32 | 84.90 | 2326 | 2722 | 0.8544 | 0.9381 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 35.03 | 84.90 | 71 | 2991 | 0.0237 | -0.0342 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 35.03 | 84.90 | 2128 | 2991 | 0.7114 | 0.8718 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 35.03 | 84.90 | 101 | 2991 | 0.0338 | 0.0344 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 35.03 | 84.90 | 2472 | 2991 | 0.8264 | 0.9272 | MN20160318_Q02 | J17 |